Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 8, 2013 - Issue 3
Submit an article Journal homepage
81
Views
4
CrossRef citations to date
0
Altmetric
Drug Profile

Albiglutide: clinical overview of a long-acting GLP-1 receptor agonist in the treatment of Type 2 diabetes

Tracy Setji Duke University Medical Center, Durham, NC 27710, USA. [email protected]
&
Mark Feinglos Duke University Medical Center, Durham, NC 27710, USA
Pages 229-238 | Published online: 10 Jan 2014

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Malcolm A. Young, Jeffrey A. Wald, Jessica E. Matthews, Fred Yang & Rickey R. Reinhardt. (2014) Effect of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Albiglutide. Postgraduate Medicine 126:3, pages 35-46.
Read now

Articles from other publishers (3)

Yi Liu, Guohao Wang, Huimin Zhang, Ying Ma, Lixin Lang, Orit Jacobson, Dale O. Kiesewetter, Lei Zhu, Shi Gao, Qingjie Ma & Xiaoyuan Chen. (2015) Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment. Bioconjugate Chemistry 27:1, pages 54-58.
Crossref
Shaocong Hou, Caina Li, Yi Huan, Shuainan Liu, Quan Liu, Sujuan Sun, Qian Jiang, Chunming Jia & Zhufang Shen. (2015) Effects of E2HSA, a Long-Acting Glucagon Like Peptide-1 Receptor Agonist, on Glycemic Control and Beta Cell Function in Spontaneous Diabetic db/db Mice. Journal of Diabetes Research 2015, pages 1-17.
Crossref
Bo Ahrén, Susan L. Johnson, Murray Stewart, Deborah T. CirkelFred Yang, Caroline Perry & Mark N. Feinglos. (2014) HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin. Diabetes Care 37:8, pages 2141-2148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.